5 drug(s) with this reaction
14,890 total reports
Drug Dose Omission has been reported as an adverse reaction across 5 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 14,890 adverse event reports mention drug dose omission in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with drug dose omission, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have drug dose omission listed in their FDA adverse event reports, sorted by report count:
In addition to drug dose omission, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
5 drug(s) manufactured by Amgen Inc have drug dose omission listed in their FDA adverse event reports: CINACALCET HYDROCHLORIDE, APREMILAST, PEGFILGRASTIM, DENOSUMAB, ROMIPLOSTIM.
There are a combined 14,890 reports of drug dose omission across 5 Amgen Inc drug(s) in the FDA adverse event database.